{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:58:06Z","timestamp":1793642286148,"version":"4.5.1"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences and Health ServicesTehran University of Medical Sciences and Health Services","award":["33135"],"award-info":[{"award-number":["33135"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jpsychires.2018.04.022","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T15:12:31Z","timestamp":1525187551000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial"],"prefix":"10.1016","volume":"103","author":[{"given":"Mona","family":"Khalaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amene","family":"Saghazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-9035","authenticated-orcid":false,"given":"Elham","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Shalbafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitera Hakim","family":"Shooshtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Yousefi","family":"Laksari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryamalsadat","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Akhondzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-230X-11-22","article-title":"Gastrointestinal flora and gastrointestinal status in children with autism\u2013comparisons to typical children and correlation with autism severity","volume":"11","author":"Adams","year":"2011","journal-title":"BMC Gstroenterology"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2710.1999.00231.x","article-title":"Hippocampal synaptic plasticity and cognition","volume":"24","author":"Akhondzadeh","year":"1999","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2710.2000.00295.x","article-title":"Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal","volume":"25","author":"Akhondzadeh","year":"2000","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10578-007-0084-3","article-title":"A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder","volume":"39","author":"Akhondzadeh","year":"2008","journal-title":"Child Psychiatr. Hum. Dev."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib5","first-page":"283","article-title":"The Aberrant Behavior Checklist-Community: factor validity and effect of subject variables for adults in group homes","volume":"100","author":"Aman","year":"1995","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib6","series-title":"Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: a Report of Two Cases","author":"Antonucci","year":"2015"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-012-2796-8","article-title":"Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"225","author":"Asadabadi","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2018.04.022_bib8","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","author":"Association","year":"2013"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF02212194","article-title":"Social and pragmatic deficits in autism: cognitive or affective?","volume":"18","author":"Baron-Cohen","year":"1988","journal-title":"J. Autism Dev. Disord."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaac.2014.01.018","article-title":"Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism","volume":"53","author":"Bent","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial effects of Co-Ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/092986709787002745","article-title":"Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders","volume":"16","author":"Blaylock","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0704900","article-title":"Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems","volume":"137","author":"Costa","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/jmf.2013.0165","article-title":"Effect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up","volume":"17","author":"Costagliola","year":"2014","journal-title":"J. Med. Food"},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/apt.13958","article-title":"Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome","volume":"45","author":"Cremon","year":"2017","journal-title":"Aliment Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib16","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"D'Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib18","first-page":"387","article-title":"Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study","volume":"107","author":"Degenhardt","year":"2007","journal-title":"J. Am. Osteopath. Assoc."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.04.022_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib21","first-page":"55","article-title":"Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries","volume":"12","author":"Esposito","year":"2013","journal-title":"CNS Neurol. Disord. - Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib22","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1167\/iovs.10-7057","article-title":"Ocular hypotensive effect of oral palmitoyl-ethanolamide: a clinical trial","volume":"52","author":"Gagliano","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","article-title":"Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis","volume":"13","author":"Gatti","year":"2012","journal-title":"Pain Med. (Malden, Mass.)"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/jpet.108.136903","article-title":"Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury","volume":"326","author":"Genovese","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.04.022_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027257","article-title":"High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women","volume":"6","author":"Ghafouri","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S1461145712000880","article-title":"Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Ghaleiha","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0269881113508830","article-title":"Galantamine efficacy and tolerability as an augmentative therapy in autistic children: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ghaleiha","year":"2014","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4081\/aiua.2017.1.17","article-title":"The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis\/chronic pelvic pain syndrome: a randomized clinical trial","volume":"89","author":"Giammusso","year":"2017","journal-title":"Arch. Ital. Urol. Androl. Organo Ufficiale [di] Societa Italiana di Ecografia Urologica e Nefrologica"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib29","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/1467-9566.00316","article-title":"\u2018Everybody just freezes. Everybody is just embarrassed\u2019: felt and enacted stigma among parents of children with high functioning autism","volume":"24","author":"Gray","year":"2002","journal-title":"Sociol. Health Illness"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamapediatrics.2014.1893","article-title":"Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices","volume":"169","author":"Hansen","year":"2015","journal-title":"JAMA pediatrics"},{"issue":"11","key":"10.1016\/j.jpsychires.2018.04.022_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.biopsych.2012.01.014","article-title":"A randomized controlled pilot trial of oral N-acetylcysteine in children with autism","volume":"71","author":"Hardan","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/cap.2006.0056","article-title":"Risperidone-induced enuresis in two children with autistic disorder","volume":"17","author":"Herg\u00fcner","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/JPR.S32143","article-title":"Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series","volume":"5","author":"Hesselink","year":"2012","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/DBP.0b013e3182040acf","article-title":"Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments","volume":"32","author":"Huffman","year":"2011","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejogrb.2010.01.008","article-title":"Effect of palmitoylethanolamide\u2013polydatin combination on chronic pelvic pain associated with endometriosis: preliminary observations","volume":"150","author":"Indraccolo","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","article-title":"The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain","volume":"76","author":"Jaggar","year":"1998","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cercor\/bhl006","article-title":"Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry","volume":"17","author":"Just","year":"2006","journal-title":"Cerebr. Cortex"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033537","article-title":"Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections","volume":"7","author":"Kallendrusch","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000098702","article-title":"Endogenous phospholipid metabolite containing topical product inhibits ultraviolet light-induced inflammation and DNA damage in human skin","volume":"20","author":"Kemeny","year":"2007","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2147\/JPR.S93106","article-title":"Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome","volume":"8","author":"Keppel Hesselink","year":"2015","journal-title":"J. Pain Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/10937400600882079","article-title":"Evidence of toxicity, oxidative stress, and neuronal insult in autism","volume":"9","author":"Kern","year":"2006","journal-title":"J. Toxicol. Environ. Health B"},{"key":"10.1016\/j.jpsychires.2018.04.022_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1362361300004002002","article-title":"The prevalence of anxiety and mood problems among children with autism and Asperger syndrome","volume":"4","author":"Kim","year":"2000","journal-title":"Autism"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib44","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1528-1157.2001.41499.x","article-title":"Anticonvulsant activity of N-Palmitoylethanolamide, a putative endocannabinoid, in mice","volume":"42","author":"Lambert","year":"2001","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib45","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2788.2005.00732.x","article-title":"The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders","volume":"50","author":"Lecavalier","year":"2006","journal-title":"J. Intellect. Disabil. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10673220802075852","article-title":"Pharmacological treatment options for autism spectrum disorders in children and adolescents","volume":"16","author":"Leskovec","year":"2008","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib47","first-page":"5","article-title":"Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity","volume":"55","author":"Leysen","year":"1994","journal-title":"J. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib48","first-page":"453","article-title":"Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results","volume":"65","author":"Lo Monte","year":"2013","journal-title":"Minerva Ginecol."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib49","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF02172145","article-title":"Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders","volume":"24","author":"Lord","year":"1994","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00004583-200202000-00007","article-title":"Risperidone treatment in children and adolescents with autism: short-and long-term safety and effectiveness","volume":"41","author":"Malone","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib51","first-page":"99","article-title":"Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain","volume":"26","author":"Marini","year":"2012","journal-title":"J. Orofac. Pain"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib52","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/mp.2014.59","article-title":"Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis","volume":"20","author":"Masi","year":"2015","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042399","article-title":"Endocannabinoids measurement in human saliva as potential biomarker of obesity","volume":"7","author":"Matias","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib54","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib55","series-title":"The Aberrant Behavior Checklist: a Behavior Rating Scale for the Assessment of Treatment Effects","author":"MianEl","year":"1985"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/cap.2017.0055","article-title":"Simvastatin as an adjunctive therapy to risperidone in treatment of autism: a randomized, double-blind, placebo-controlled clinical trial","volume":"28","author":"Moazen-Zadeh","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.biopsych.2010.05.024","article-title":"Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism","volume":"68","author":"Morgan","year":"2010","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2007.05.015","article-title":"Microglia produce and hydrolyze palmitoylethanolamide","volume":"54","author":"Muccioli","year":"2008","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020766","article-title":"Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats","volume":"6","author":"Murillo-Rodr\u00edguez","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib60","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/08830738060210060801","article-title":"Risperidone in children with autism: randomized, placebo-controlled, double-blind study","volume":"21","author":"Nagaraj","year":"2006","journal-title":"J. Child Neurol."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2710.1999.00238.x","article-title":"Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia","volume":"24","author":"Noorbala","year":"1999","journal-title":"J. Clin. Pharm. Therapeut."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/WNF.0000000000000063","article-title":"N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety","volume":"38","author":"Nikoo","year":"2015","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib63","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/vde.12250","article-title":"Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study","volume":"26","author":"Noli","year":"2015","journal-title":"Vet. Dermatol."},{"issue":"12","key":"10.1016\/j.jpsychires.2018.04.022_bib64","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1097\/j.pain.0000000000000687","article-title":"N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism","volume":"157","author":"Okine","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/1742-2094-10-20","article-title":"Molecular evidence for the involvement of PPAR-\u03b4 and PPAR-\u03b3 in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma","volume":"10","author":"Paterniti","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.04.022_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jop.2010.0191","article-title":"Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study","volume":"27","author":"Pescosolido","year":"2011","journal-title":"J. Ocul. Pharmacol. Therapeut. Official J. Assoc. Ocul. Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib67","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/WNL.57.9.1618","article-title":"Postmortem brain abnormalities of the glutamate neurotransmitter system in autism","volume":"57","author":"Purcell","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004583-200203000-00014","article-title":"Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study","volume":"41","author":"Ratzoni","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib69","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1586\/14737175.8.4.657","article-title":"Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment","volume":"8","author":"Reiersen","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.04.022_bib70","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months","volume":"162","author":"Research Units on Pediatric Psychopharmacology Autism","year":"2005","journal-title":"Am. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib71","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.rasd.2010.12.003","article-title":"Review of gender differences in core symptomatology in autism spectrum disorders","volume":"5","author":"Rivet","year":"2011","journal-title":"Res. Autism Spect. Disorder"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","article-title":"A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures","volume":"17","author":"Rossignol","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib74","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.jpsychires.2018.04.022_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025340","article-title":"Alteration of plasma glutamate and glutamine levels in children with high-functioning autism","volume":"6","author":"Shimmura","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jpsychires.2018.04.022_bib76","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.pnpbp.2006.06.013","article-title":"Increased serum levels of glutamate in adult patients with autism","volume":"30","author":"Shinohe","year":"2006","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.04.022_bib77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02256592","article-title":"Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism","volume":"9","author":"Singh","year":"2002","journal-title":"J. Biomed. Sci."},{"issue":"49","key":"10.1016\/j.jpsychires.2018.04.022_bib78","doi-asserted-by":"crossref","first-page":"20966","DOI":"10.1073\/pnas.0907417106","article-title":"Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation","volume":"106","author":"Solorzano","year":"2009","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.04.022_bib79","first-page":"801","article-title":"[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus]. Der Hautarzt; Zeitschrift Fur Dermatologie","volume":"57","author":"Stander","year":"2006","journal-title":"Venerologie und verwandte Gebiete"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.04.022_bib80","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1167\/iovs.12-10899","article-title":"Effectiveness of palmitoylethanolamide on endothelial dysfunction in ocular hypertensive patients: a randomized, placebo-controlled cross-over study","volume":"54","author":"Strobbe","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","article-title":"Microglial activation in young adults with autism spectrum disorder","volume":"70","author":"Suzuki","year":"2013","journal-title":"JAMA psychiatry"},{"issue":"5","key":"10.1016\/j.jpsychires.2018.04.022_bib82","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.clinthera.2013.04.006","article-title":"An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders","volume":"35","author":"Taliou","year":"2013","journal-title":"Clin. Therapeut."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.04.022_bib83","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.chi.0000177055.11229.76","article-title":"Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study","volume":"44","author":"Troost","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.04.022_bib84","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2174\/187152711799219307","article-title":"Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy","volume":"10","author":"Truini","year":"2011","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.04.022_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Verme","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/039463200301600302","article-title":"Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism","volume":"16","author":"Vojdani","year":"2003","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib87","author":"World Medical"},{"issue":"3","key":"10.1016\/j.jpsychires.2018.04.022_bib88","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1734-1140(11)70596-5","article-title":"N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice","volume":"63","author":"Yu","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jpsychires.2018.04.022_bib89","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/CIA.S65448","article-title":"N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients","volume":"9","author":"Yuan","year":"2014","journal-title":"Clin. Interv. Aging"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561731405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002239561731405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T12:02:38Z","timestamp":1720267358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002239561731405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":89,"alternative-id":["S002239561731405X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.022","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}